Table of Content

1 Bevacizumab Injection Market Overview
1.1 Bevacizumab Injection Product Overview
1.2 Bevacizumab Injection Market Segment by Type
1.2.1 100mg
1.2.2 400mg
1.3 Global Bevacizumab Injection Market Size by Type
1.3.1 Global Bevacizumab Injection Market Size Overview by Type (2024-2034)
1.3.2 Global Bevacizumab Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global Bevacizumab Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bevacizumab Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe Bevacizumab Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Bevacizumab Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Bevacizumab Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Bevacizumab Injection Sales Breakdown by Type (2024-2024)
2 Global Bevacizumab Injection Market Competition by Company
2.1 Global Top Players by Bevacizumab Injection Sales (2024-2024)
2.2 Global Top Players by Bevacizumab Injection Revenue (2024-2024)
2.3 Global Top Players by Bevacizumab Injection Price (2024-2024)
2.4 Global Top Manufacturers Bevacizumab Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bevacizumab Injection Market Competitive Situation and Trends
2.5.1 Bevacizumab Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Bevacizumab Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bevacizumab Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Bevacizumab Injection Market
2.8 Key Manufacturers Bevacizumab Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bevacizumab Injection Status and Outlook by Region
3.1 Global Bevacizumab Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Bevacizumab Injection Historic Market Size by Region
3.2.1 Global Bevacizumab Injection Sales in Volume by Region (2024-2024)
3.2.2 Global Bevacizumab Injection Sales in Value by Region (2024-2024)
3.2.3 Global Bevacizumab Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Bevacizumab Injection Forecasted Market Size by Region
3.3.1 Global Bevacizumab Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Bevacizumab Injection Sales in Value by Region (2024-2034)
3.3.3 Global Bevacizumab Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Bevacizumab Injection by Application
4.1 Bevacizumab Injection Market Segment by Application
4.1.1 Age-related macular degeneration (AMD)
4.1.2 Ovarian Cancer
4.1.3 Others
4.2 Global Bevacizumab Injection Market Size by Application
4.2.1 Global Bevacizumab Injection Market Size Overview by Application (2024-2034)
4.2.2 Global Bevacizumab Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global Bevacizumab Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bevacizumab Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe Bevacizumab Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Bevacizumab Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Bevacizumab Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Bevacizumab Injection Sales Breakdown by Application (2024-2024)
5 North America Bevacizumab Injection by Country
5.1 North America Bevacizumab Injection Historic Market Size by Country
5.1.1 North America Bevacizumab Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Bevacizumab Injection Sales in Volume by Country (2024-2024)
5.1.3 North America Bevacizumab Injection Sales in Value by Country (2024-2024)
5.2 North America Bevacizumab Injection Forecasted Market Size by Country
5.2.1 North America Bevacizumab Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Bevacizumab Injection Sales in Value by Country (2024-2034)
6 Europe Bevacizumab Injection by Country
6.1 Europe Bevacizumab Injection Historic Market Size by Country
6.1.1 Europe Bevacizumab Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Bevacizumab Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe Bevacizumab Injection Sales in Value by Country (2024-2024)
6.2 Europe Bevacizumab Injection Forecasted Market Size by Country
6.2.1 Europe Bevacizumab Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Bevacizumab Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Bevacizumab Injection by Region
7.1 Asia-Pacific Bevacizumab Injection Historic Market Size by Region
7.1.1 Asia-Pacific Bevacizumab Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Bevacizumab Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Bevacizumab Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Bevacizumab Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Bevacizumab Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Bevacizumab Injection Sales in Value by Region (2024-2034)
8 Latin America Bevacizumab Injection by Country
8.1 Latin America Bevacizumab Injection Historic Market Size by Country
8.1.1 Latin America Bevacizumab Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Bevacizumab Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America Bevacizumab Injection Sales in Value by Country (2024-2024)
8.2 Latin America Bevacizumab Injection Forecasted Market Size by Country
8.2.1 Latin America Bevacizumab Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Bevacizumab Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Bevacizumab Injection by Country
9.1 Middle East and Africa Bevacizumab Injection Historic Market Size by Country
9.1.1 Middle East and Africa Bevacizumab Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Bevacizumab Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Bevacizumab Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Bevacizumab Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Bevacizumab Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Bevacizumab Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer Bevacizumab Injection Products Offered
10.1.5 Pfizer Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Roche Bevacizumab Injection Products Offered
10.2.5 Roche Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Eli Lilly Bevacizumab Injection Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Genentech
10.4.1 Genentech Company Information
10.4.2 Genentech Introduction and Business Overview
10.4.3 Genentech Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Genentech Bevacizumab Injection Products Offered
10.4.5 Genentech Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Bayer Bevacizumab Injection Products Offered
10.5.5 Bayer Recent Development
10.6 Amgen
10.6.1 Amgen Company Information
10.6.2 Amgen Introduction and Business Overview
10.6.3 Amgen Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Amgen Bevacizumab Injection Products Offered
10.6.5 Amgen Recent Development
10.7 Samsung Bioepis
10.7.1 Samsung Bioepis Company Information
10.7.2 Samsung Bioepis Introduction and Business Overview
10.7.3 Samsung Bioepis Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Samsung Bioepis Bevacizumab Injection Products Offered
10.7.5 Samsung Bioepis Recent Development
10.8 Centus
10.8.1 Centus Company Information
10.8.2 Centus Introduction and Business Overview
10.8.3 Centus Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Centus Bevacizumab Injection Products Offered
10.8.5 Centus Recent Development
10.9 Cadila Pharmaceuticals
10.9.1 Cadila Pharmaceuticals Company Information
10.9.2 Cadila Pharmaceuticals Introduction and Business Overview
10.9.3 Cadila Pharmaceuticals Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Cadila Pharmaceuticals Bevacizumab Injection Products Offered
10.9.5 Cadila Pharmaceuticals Recent Development
10.10 Dr Reddy's
10.10.1 Dr Reddy's Company Information
10.10.2 Dr Reddy's Introduction and Business Overview
10.10.3 Dr Reddy's Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Dr Reddy's Bevacizumab Injection Products Offered
10.10.5 Dr Reddy's Recent Development
10.11 Mylan
10.11.1 Mylan Company Information
10.11.2 Mylan Introduction and Business Overview
10.11.3 Mylan Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Mylan Bevacizumab Injection Products Offered
10.11.5 Mylan Recent Development
10.12 Hetero Group
10.12.1 Hetero Group Company Information
10.12.2 Hetero Group Introduction and Business Overview
10.12.3 Hetero Group Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Hetero Group Bevacizumab Injection Products Offered
10.12.5 Hetero Group Recent Development
10.13 Biocon
10.13.1 Biocon Company Information
10.13.2 Biocon Introduction and Business Overview
10.13.3 Biocon Bevacizumab Injection Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Biocon Bevacizumab Injection Products Offered
10.13.5 Biocon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bevacizumab Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bevacizumab Injection Industrial Chain Analysis
11.4 Bevacizumab Injection Market Dynamics
11.4.1 Bevacizumab Injection Industry Trends
11.4.2 Bevacizumab Injection Market Drivers
11.4.3 Bevacizumab Injection Market Challenges
11.4.4 Bevacizumab Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bevacizumab Injection Distributors
12.3 Bevacizumab Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 100mg
Table 2. Major Company of 400mg
Table 3. Global Bevacizumab Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Bevacizumab Injection Sales by Type (2024-2024) & (K Doses)
Table 5. Global Bevacizumab Injection Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Bevacizumab Injection Sales by Type (2024-2024) & (US& Million)
Table 7. Global Bevacizumab Injection Market Share in Value by Type (2024-2024)
Table 8. Global Bevacizumab Injection Price by Type (2024-2024) & (US$/Dose)
Table 9. Global Bevacizumab Injection Sales by Type (2024-2034) & (K Doses)
Table 10. Global Bevacizumab Injection Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Bevacizumab Injection Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Bevacizumab Injection Sales Market Share in Value by Type (2024-2034)
Table 13. Global Bevacizumab Injection Price by Type (2024-2034) & (US$/Dose)
Table 14. North America Bevacizumab Injection Sales by Type (2024-2024) & (K Doses)
Table 15. North America Bevacizumab Injection Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Bevacizumab Injection Sales (K Doses) by Type (2024-2024)
Table 17. Europe Bevacizumab Injection Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Bevacizumab Injection Sales (K Doses) by Type (2024-2024)
Table 19. Asia-Pacific Bevacizumab Injection Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Bevacizumab Injection Sales (K Doses) by Type (2024-2024)
Table 21. Latin America Bevacizumab Injection Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Bevacizumab Injection Sales (K Doses) by Type (2024-2024)
Table 23. Middle East and Africa Bevacizumab Injection Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Bevacizumab Injection Sales by Company (2024-2024) & (K Doses)
Table 25. Global Bevacizumab Injection Sales Share by Company (2024-2024)
Table 26. Global Bevacizumab Injection Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Bevacizumab Injection Revenue Share by Company (2024-2024)
Table 28. Global Market Bevacizumab Injection Price by Company (2024-2024) & (US$/Dose)
Table 29. Global Bevacizumab Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Bevacizumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bevacizumab Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Bevacizumab Injection Market
Table 33. Key Manufacturers Bevacizumab Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Bevacizumab Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Bevacizumab Injection Sales by Region (2024-2024) & (K Doses)
Table 37. Global Bevacizumab Injection Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Bevacizumab Injection Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Bevacizumab Injection Sales Market Share in Value by Region (2024-2024)
Table 40. Global Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 41. Global Bevacizumab Injection Sales by Region (2024-2034) & (K Doses)
Table 42. Global Bevacizumab Injection Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Bevacizumab Injection Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Bevacizumab Injection Sales Market Share in Value by Region (2024-2034)
Table 45. Global Bevacizumab Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2034)
Table 46. Global Bevacizumab Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Bevacizumab Injection Sales by Application (2024-2024) & (K Doses)
Table 48. Global Bevacizumab Injection Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Bevacizumab Injection Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Bevacizumab Injection Sales Market Share in Value by Application (2024-2024)
Table 51. Global Bevacizumab Injection Price by Application (2024-2024) & (US$/Dose)
Table 52. Global Bevacizumab Injection Sales by Application (2024-2034) & (K Doses)
Table 53. Global Bevacizumab Injection Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Bevacizumab Injection Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Bevacizumab Injection Sales Market Share in Value by Application (2024-2034)
Table 56. Global Bevacizumab Injection Price by Application (2024-2034) & (US$/Dose)
Table 57. North America Bevacizumab Injection Sales by Application (2024-2024) (K Doses)
Table 58. North America Bevacizumab Injection Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Bevacizumab Injection Sales by Application (2024-2024) (K Doses)
Table 60. Europe Bevacizumab Injection Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Bevacizumab Injection Sales by Application (2024-2024) (K Doses)
Table 62. Asia-Pacific Bevacizumab Injection Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Bevacizumab Injection Sales by Application (2024-2024) (K Doses)
Table 64. Latin America Bevacizumab Injection Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Bevacizumab Injection Sales by Application (2024-2024) (K Doses)
Table 66. Middle East and Africa Bevacizumab Injection Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Bevacizumab Injection Sales by Country (2024-2024) & (K Doses)
Table 68. North America Bevacizumab Injection Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Bevacizumab Injection Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Bevacizumab Injection Sales Market Share in Value by Country (2024-2024)
Table 71. North America Bevacizumab Injection Sales by Country (2024-2034) & (K Doses)
Table 72. North America Bevacizumab Injection Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Bevacizumab Injection Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Bevacizumab Injection Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Bevacizumab Injection Sales by Country (2024-2024) & (K Doses)
Table 76. Europe Bevacizumab Injection Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Bevacizumab Injection Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Bevacizumab Injection Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Bevacizumab Injection Sales by Country (2024-2034) & (K Doses)
Table 80. Europe Bevacizumab Injection Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Bevacizumab Injection Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Bevacizumab Injection Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Bevacizumab Injection Sales by Region (2024-2024) & (K Doses)
Table 84. Asia-Pacific Bevacizumab Injection Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Bevacizumab Injection Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Bevacizumab Injection Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Bevacizumab Injection Sales by Region (2024-2034) & (K Doses)
Table 88. Asia-Pacific Bevacizumab Injection Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Bevacizumab Injection Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Bevacizumab Injection Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Bevacizumab Injection Sales by Country (2024-2024) & (K Doses)
Table 92. Latin America Bevacizumab Injection Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Bevacizumab Injection Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Bevacizumab Injection Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Bevacizumab Injection Sales by Country (2024-2034) & (K Doses)
Table 96. Latin America Bevacizumab Injection Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Bevacizumab Injection Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Bevacizumab Injection Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Bevacizumab Injection Sales by Country (2024-2024) & (K Doses)
Table 100. Middle East and Africa Bevacizumab Injection Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Bevacizumab Injection Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Bevacizumab Injection Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Bevacizumab Injection Sales by Country (2024-2034) & (K Doses)
Table 104. Middle East and Africa Bevacizumab Injection Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Bevacizumab Injection Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Bevacizumab Injection Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 110. Pfizer Bevacizumab Injection Product
Table 111. Pfizer Recent Development
Table 112. Roche Company Information
Table 113. Roche Introduction and Business Overview
Table 114. Roche Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 115. Roche Bevacizumab Injection Product
Table 116. Roche Recent Development
Table 117. Eli Lilly Company Information
Table 118. Eli Lilly Introduction and Business Overview
Table 119. Eli Lilly Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 120. Eli Lilly Bevacizumab Injection Product
Table 121. Eli Lilly Recent Development
Table 122. Genentech Company Information
Table 123. Genentech Introduction and Business Overview
Table 124. Genentech Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 125. Genentech Bevacizumab Injection Product
Table 126. Genentech Recent Development
Table 127. Bayer Company Information
Table 128. Bayer Introduction and Business Overview
Table 129. Bayer Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 130. Bayer Bevacizumab Injection Product
Table 131. Bayer Recent Development
Table 132. Amgen Company Information
Table 133. Amgen Introduction and Business Overview
Table 134. Amgen Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 135. Amgen Bevacizumab Injection Product
Table 136. Amgen Recent Development
Table 137. Samsung Bioepis Company Information
Table 138. Samsung Bioepis Introduction and Business Overview
Table 139. Samsung Bioepis Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 140. Samsung Bioepis Bevacizumab Injection Product
Table 141. Samsung Bioepis Recent Development
Table 142. Centus Company Information
Table 143. Centus Introduction and Business Overview
Table 144. Centus Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 145. Centus Bevacizumab Injection Product
Table 146. Centus Recent Development
Table 147. Cadila Pharmaceuticals Company Information
Table 148. Cadila Pharmaceuticals Introduction and Business Overview
Table 149. Cadila Pharmaceuticals Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 150. Cadila Pharmaceuticals Bevacizumab Injection Product
Table 151. Cadila Pharmaceuticals Recent Development
Table 152. Dr Reddy's Company Information
Table 153. Dr Reddy's Introduction and Business Overview
Table 154. Dr Reddy's Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 155. Dr Reddy's Bevacizumab Injection Product
Table 156. Dr Reddy's Recent Development
Table 157. Mylan Company Information
Table 158. Mylan Introduction and Business Overview
Table 159. Mylan Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 160. Mylan Bevacizumab Injection Product
Table 161. Mylan Recent Development
Table 162. Hetero Group Company Information
Table 163. Hetero Group Introduction and Business Overview
Table 164. Hetero Group Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 165. Hetero Group Bevacizumab Injection Product
Table 166. Hetero Group Recent Development
Table 167. Biocon Company Information
Table 168. Biocon Introduction and Business Overview
Table 169. Biocon Bevacizumab Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2024-2024)
Table 170. Biocon Bevacizumab Injection Product
Table 171. Biocon Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Bevacizumab Injection Market Trends
Table 175. Bevacizumab Injection Market Drivers
Table 176. Bevacizumab Injection Market Challenges
Table 177. Bevacizumab Injection Market Restraints
Table 178. Bevacizumab Injection Distributors List
Table 179. Bevacizumab Injection Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Bevacizumab Injection Product Picture
Figure 2. Global Bevacizumab Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Bevacizumab Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Bevacizumab Injection Sales Status and Outlook (2024-2034) & (K Doses)
Figure 5. Product Picture of 100mg
Figure 6. Global 100mg Sales YoY Growth (2024-2034) & (K Doses)
Figure 7. Product Picture of 400mg
Figure 8. Global 400mg Sales YoY Growth (2024-2034) & (K Doses)
Figure 9. Global Bevacizumab Injection Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Bevacizumab Injection Sales Market Share by Type in 2022 & 2034
Figure 11. North America Bevacizumab Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Bevacizumab Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Bevacizumab Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Bevacizumab Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Bevacizumab Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Bevacizumab Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Bevacizumab Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Bevacizumab Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Bevacizumab Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Bevacizumab Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Bevacizumab Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Bevacizumab Injection Revenue in 2022
Figure 23. Bevacizumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Age-related macular degeneration (AMD)
Figure 25. Global Age-related macular degeneration (AMD) Sales YoY Growth (2024-2034) & (K Doses)
Figure 26. Product Picture of Ovarian Cancer
Figure 27. Global Ovarian Cancer Sales YoY Growth (2024-2034) & (K Doses)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Doses)
Figure 30. Global Bevacizumab Injection Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Bevacizumab Injection Sales Market Share by Application in 2022 & 2034
Figure 32. North America Bevacizumab Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Bevacizumab Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Bevacizumab Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Bevacizumab Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Bevacizumab Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Bevacizumab Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Bevacizumab Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Bevacizumab Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Bevacizumab Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Bevacizumab Injection Manufacturing Cost Structure
Figure 43. Bevacizumab Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed